melenoma
Conditions
Interventions
Sponsors
Peking University Cancer Hospital and Institute
Eligibility
Sex/Gender
All
Age
18 Years to 84 Years
Inclusion criteria
Inclusion criteria: 1. age more than 18 years; 2. ECOG performance status of 0 or 1; 3. pathologically confirmed diagnosis of MM; 4. complete resection of primary diseases; 5. no prior systemic adjuvant therapy; 6. no evidence of distant metastatic disease identi?ed by means of lymph nodes ultrasound and whole body spiral computed tomography (CT) or positron emission tomography-CT (PET-CT); 7. normal bone marrow function; and adequate liver chemistry and renal function (including WBC>3,000/mm3, absolute neutrophil count>1,500/mm3, platelets>100,000/mm3, serum creatinine less than two times of the upper limit of normal (ULN), bilirubin less than 1.5 times of ULN, AST and ALT less than 2.5 times of ULN, international normalized ratio less than 1.5 times of ULN, and partial thromboplastin time less than ULN).
Exclusion criteria
Exclusion criteria: 1. cutaneous melanoma or ocular melanoma or melanoma of unknown primary site; 2. incomplete resection, a second cancer diagnosis; 3. definite medical history of cirrhoses of the liver or autoimmune diseases; 4. severe depression and pregnant or lactating female.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| relapse free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival; | — |
Countries
China
Contacts
Public ContactGuo Jun
Outcome results
None listed